Ignite Creation Date:
2025-12-25 @ 1:27 AM
Ignite Modification Date:
2026-05-15 @ 6:00 PM
Study NCT ID:
NCT01119794
Status:
TERMINATED
Last Update Posted:
2015-08-26
First Post:
2010-05-06
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Ofatumumab and Bortezomib for Patients With Low-grade B-cell Non-hodgkin Lymphoma That Relapse After Rituximab
Sponsor:
Organization: